| review article | Q7318358 |
| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Geneviève Chêne | Q33101711 |
| Yazdan Yazdanpanah | Q88536415 | ||
| P2093 | author name string | Marcel Zwahlen | |
| Matthias Egger | |||
| Daouda Sissoko | |||
| Yves Mouton | |||
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy | Q28367526 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 | ||
| Guidelines for using antiretroviral agents among HIV-infected adults and adolescents | Q33964717 | ||
| Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. | Q34068078 | ||
| A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients | Q34191241 | ||
| Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis | Q34307827 | ||
| A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team | Q34438252 | ||
| A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study | Q34464169 | ||
| Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. | Q34719319 | ||
| Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study | Q36247045 | ||
| Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance | Q38884246 | ||
| Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses | Q39735046 | ||
| Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection | Q43702175 | ||
| Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study | Q43782897 | ||
| Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients | Q43820402 | ||
| Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study | Q43820991 | ||
| Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group | Q43898486 | ||
| Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study | Q43945659 | ||
| Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. | Q44043469 | ||
| Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team | Q44088437 | ||
| A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study). | Q44126097 | ||
| Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens | Q44406929 | ||
| A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A S | Q44594900 | ||
| A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy | Q45747981 | ||
| Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy | Q45760702 | ||
| Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group | Q45771512 | ||
| Explaining heterogeneity in meta-analysis: a comparison of methods. | Q52141807 | ||
| Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P | Q53986252 | ||
| A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. | Q54434797 | ||
| A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease | Q59306907 | ||
| From the Centers for Disease Control and prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q72940668 | ||
| Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group | Q74213228 | ||
| Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team | Q78066986 | ||
| Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group | Q78175792 | ||
| P433 | issue | 7434 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 249 | |
| P577 | publication date | 2004-01-23 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials | |
| P478 | volume | 328 |
| Q43138084 | Access to antiretroviral treatment in Africa |
| Q35751916 | Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents |
| Q36381197 | Bayesian methods for evidence synthesis in cost-effectiveness analysis |
| Q53455078 | CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. |
| Q33933071 | Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database |
| Q37110309 | Clinically informative measures of the effect of drugs or other interventions |
| Q53015754 | Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000. |
| Q35727819 | Confidentiality of the medical records of HIV-positive patients in the United Kingdom - a medicolegal and ethical perspective |
| Q57175680 | Detection of Adverse Drug Reaction Signals in the Thai FDA Database: Comparison between Reporting Odds Ratio and Bayesian Confidence Propagation Neural Network Methods |
| Q37381677 | Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future |
| Q36568414 | Disease management--constructing optimal NRTI-based combinations: past, present, and future. |
| Q34727977 | Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV |
| Q46843869 | Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation |
| Q33891656 | Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data |
| Q40802236 | Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis |
| Q35629139 | Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs |
| Q33750311 | Indirect comparisons: a review of reporting and methodological quality |
| Q51929967 | Indirect comparisons: the mesh and mess of clinical trials. |
| Q36637482 | Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses |
| Q38305425 | Insight into HIV-1 reverse transcriptase-aptamer interaction from molecular dynamics simulations |
| Q36084505 | Medical decision making with incomplete evidence--choosing a platelet glycoprotein IIbIIIa receptor inhibitor for percutaneous coronary interventions |
| Q36286228 | Nelfinavir: a review of its use in the management of HIV infection |
| Q38811335 | Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. |
| Q37272301 | Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis |
| Q30483561 | Real-time updates of meta-analyses of HIV treatments supported by a biomedical ontology |
| Q36614066 | Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy |
| Q36457016 | Retrovirus vectors: toward the plentivirus? |
| Q34081552 | Simultaneous comparison of multiple treatments: combining direct and indirect evidence. |
| Q24246038 | Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults |
| Q50632332 | The HIV positive dentist in the United Kingdom - the dilemma of the undiagnosed clinician. |
| Q84285826 | The HIV positive dentist in the United Kingdom--a legal perspective |
Search more.